Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromesT Nösslinger, H Tüchler, U Germing, et al.
Leukemia|January 29, 2011
Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevanceA Thiel, M Beier, D Ingenhag, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 19, 2002
[Dynamic MRI of the lumbar spine for the evaluation of microcirculation during anti-angiogenetic therapy in patients with myelodysplastic syndromes]A Scherer, C Strupp, H J Wittsack, et al.
Annals of Hematology|November 7, 2020
Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromesA Kasprzak, K Nachtkamp, M Kondakci, et al.
Leukemia|October 31, 2003
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31A A N Giagounidis, U Germing, S Haase, et al.
Bone Marrow Transplantation|October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysisA Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myelomaG Kobbe, I Bruns, T Schroeder, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Annals of Hematology|March 9, 2022
Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysisA Boquoi, S M Banahan, A Mohring, et al.
Leukemia|February 20, 2003
The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AMLA Kaeferstein, U Krug, J Tiesmeier, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromesT Nösslinger, H Tüchler, U Germing, et al.
Leukemia|January 29, 2011
Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevanceA Thiel, M Beier, D Ingenhag, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 19, 2002
[Dynamic MRI of the lumbar spine for the evaluation of microcirculation during anti-angiogenetic therapy in patients with myelodysplastic syndromes]A Scherer, C Strupp, H J Wittsack, et al.
Annals of Hematology|November 7, 2020
Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromesA Kasprzak, K Nachtkamp, M Kondakci, et al.
Leukemia|October 31, 2003
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31A A N Giagounidis, U Germing, S Haase, et al.
Bone Marrow Transplantation|October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysisA Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myelomaG Kobbe, I Bruns, T Schroeder, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Annals of Hematology|March 9, 2022
Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysisA Boquoi, S M Banahan, A Mohring, et al.
Leukemia|February 20, 2003
The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AMLA Kaeferstein, U Krug, J Tiesmeier, et al.
Pageof 13